Tata Main Hospital (TMH), established in 1908, has added the combination of Ivermectin and Doxycycline to its COVID-19 treatment protocol in addition to already adding Convalescent Plasma Therapy for the treatment of SARS-CoV-2 infected patients. The hospital has already embraced the antivirals of Remdesivir and Favipiravir under Emergency Use Authorization, which has been blessed by the Indian Council of Medical Research (ICMR).
Ivermectin Use in India
Already in use in many hospitals to address COVID-19 infections, such as Lady Hardinge Medical College, Max Hospital, Lok Nayak and others, the momentum in India is undeniable as TrialSite just reported the northern Indian state of Uttar Pradesh is embracing the antiparasitic drug as a COVID-19 regimen.
Ivermectin Use in Bangladesh
The use of Ivermectin in northwestern neighbor Bangladesh has also showed tremendous results. Several studies involving Ivermectin and COVID-19 yield results that shouldn’t be overlooked by Western pharmaceutical sponsors suggests TrialSite News, including the work of Dr. Tarek Alam and the Bangladesh Medical College.
Tata Steel Main Hospital
Now The Pioneer in India reports that the Tata conglomerate has embraced “the Wonder Drug.” During a telephone interview Dr. Rajan Choudhry, general manager, medical services for Tata Steel reports that a total of 1,455 patients were tested positive for COVID-19 at the hospital. Most of the patients originate from East Sighbhum area. Thus far, 920 have been discharged already while the hospital reports 68 deaths. The recovery rate right now is 62.2 percent.
The existing regimens include Remdesivir and Favipiravir while they have ordered Roche’s Tocilizumab. Now, the general manager told The Pioneer that they report adding Ivermectin and Doxycycline to its COVID-19 treatment protocol.
The hospital also has the greenlight to use convalescent plasma however there have been reported shortages in India leading to not enough donations from recovered COVID-19 patients. However, as TrialSite has reported, part of the problem are the inclusion and exclusion criteria.
Tata Main Hospital (TMH) has been in operation since 1908 and dedicated to serve Tata Steel employees, their families and the citizenry of Jamshedpur and peripheral locations. This hospital was the inspiration of the founders of Tata with a goal that included the health and welfare of employees.
A multi-specialty hospital that includes eight clinics across the city. With a 914 bed hospital, the provider employs about 2,000, including 300 doctors and 695 nurses and 150 paramedics, technicians and pharmacists.
The hospital reports a robust quality system including ISO 9001:2008 accredited certification since 2010. It has received NABL accreditation for being the first hospital based pathology Lab and Progressive level NABH accreditation.
Tata Main Hospital includes a Research arm as well that has a significant focus on malaria and other tropical disease